Skip to main content
MANNKIND CORP logo

MANNKIND CORP — Investor Relations & Filings

Ticker · MNKD ISIN · US56400P7069 LEI · 213800GFBCNY1ZFST722 US Manufacturing
Open in API
Filings indexed 1,205 across all filing types
Latest filing 2010-08-11 Capital/Financing Update
Country US United States of America
Listing US MNKD

About MANNKIND CORP

https://mannkindcorp.com/

MannKind Corporation is a biopharmaceutical company focused on the development and commercialization of therapeutic products and devices. The company specializes in inhaled therapies for patients with cardiometabolic and orphan lung diseases. Its portfolio includes Afrezza®, an inhaled insulin for diabetes, and Tyvaso DPI®, a dry powder inhaler for pulmonary hypertension developed in collaboration with United Therapeutics. Through its acquisition of scPharmaceuticals, MannKind also markets FUROSCIX®, a subcutaneous treatment for edema in adults with chronic heart failure. The company's pipeline is focused on expanding indications for its existing products, including a pediatric application for Afrezza.

Recent filings

Filing Released Lang Actions
424B5 Filing
Capital/Financing Update Classification · 100% confidence The document is a detailed prospectus supplement and accompanying prospectus for a public offering of common stock by MannKind Corporation. It includes information about the number of shares offered, pricing, use of proceeds, risk factors, forward-looking statements, and regulatory references such as the SEC and NASDAQ. The document is a formal offering document related to capital raising through equity issuance. It is not a financial report, earnings release, management discussion, or any other report type. It clearly fits the definition of a Capital/Financing Update (CAP), as it provides updates on company fundraising and capital structure changes through a public stock offering.
2010-08-11 English
8-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated August 11, 2010. It references a legal opinion related to a Common Stock Purchase Agreement and includes exhibits such as the opinion of Cooley LLP and their consent. The content focuses on a legal event and related exhibits rather than financial statements or detailed financial data. The document length is 2383 characters, which is relatively short and primarily serves as a regulatory announcement of a legal opinion and transaction event. It does not contain financial results, management discussion, or detailed report data. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories like capital updates or legal proceedings reports.
2010-08-11 English
8-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated August 10, 2010, which reports on several corporate events including entry into material definitive agreements related to common stock purchase agreements, unregistered sales of equity securities, and other events such as updates on regulatory submissions and manufacturing activities. The content focuses on agreements for stock sales, amendments to promissory notes, and related financial arrangements. There are no comprehensive financial statements or detailed financial performance data typical of annual or quarterly reports. The document is a current report disclosing material events and agreements rather than a full financial report or earnings release. Therefore, the appropriate classification is a Regulatory Filing (RNS), which is the fallback category for miscellaneous SEC filings like Form 8-K that do not fit other specific categories.
2010-08-11 English
4 Filing
Director's Dealing
2010-08-06 English
4 Filing
Director's Dealing
2010-08-03 English
4 Filing
Director's Dealing
2010-08-03 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.